Fortress Biotech
FBIO
#10164
Rank
A$92.72 M
Marketcap
A$2.78
Share price
-4.02%
Change (1 day)
-29.85%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): A$0.21 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are A$68.46 Million. In 2025 the company made an earning of -A$49.07 Million, an increase over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.21 B-530.17%
2025 -A$49.07 Million-72.02%
2024 -A$0.18 Billion-21.6%
2023 -A$0.23 Billion-28.03%
2022 -A$0.32 Billion29.88%
2021 -A$0.24 Billion59.8%
2020 -A$0.15 Billion1.17%
2019 -A$0.15 Billion-19.84%
2018 -A$0.19 Billion28.99%
2017 -A$0.15 Billion37.92%
2016 -A$0.11 Billion32.31%
2015 -A$78.44 Million164.31%
2014 -A$29.68 Million-45.14%
2013 -A$54.1 Million37.55%
2012 -A$39.33 Million-22.91%
2011 -A$51.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
A$0.16 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$49.53 Million-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-A$49.34 Million-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA